---
input_text: 'Five-year follow-up after balloon pulmonary valvuloplasty. OBJECTIVES:
  The aim of this study was to assess results 5 years after balloon pulmonary valvuloplasty.
  BACKGROUND: Since the technique of balloon pulmonary valvuloplasty was first reported
  in 1982, it has become the treatment of choice for pulmonary valve stenosis. In
  contrast to surgical valvotomy, the long-term outcome after balloon pulmonary valvuloplasty
  is unknown. METHODS: We reviewed the findings in 34 patients 5.2 +/- 0.8 (mean +/-
  SD) years after balloon pulmonary valvuloplasty: 27 with isolated pulmonary stenosis,
  5 with Noonan syndrome and 2 with previous surgical valvotomy. In eight patients
  (three with Noonan syndrome), a second balloon valvuloplasty was the index procedure
  for analysis. RESULTS: The transpulmonary gradient (mm Hg) was 74 +/- 34 before
  balloon pulmonary valvuloplasty, 36 +/- 26 immediately after, 22 +/- 9 at cardiac
  catheterization in 29 patients 6 +/- 0.6 months later and 19 +/- 10 by Doppler study
  at 5 years. At 5 years 26 patients (group A) had a residual gradient of < or = 20
  mm Hg; the remaining 8 (group B) had a gradient of > 20 mm Hg. Four group B patients
  had Noonan syndrome (p = 0.01). Balloon/pulmonary valve diameter ratio was larger
  for group A patients than for group B patients with isolated pulmonary stenosis
  (1.20 +/- 0.10 vs. 1.00 +/- 0.07, p = 0.005); larger balloons were used in group
  B patients with Noonan syndrome (1.30 +/- 0.10). Group A patients were more likely
  than group B patients to have significant pulmonary incompetence (6 of 24 vs. 0
  of 8) and had a greater right ventricle/left ventricle long-axis diastolic dimension
  ratio (0.47 +/- 0.10 vs. 0.35 +/- 0.04, p = 0.05). In the subgroup of five patients
  with Noonan syndrome and two with prior surgical valvotomy, the transpulmonary gradient
  was reduced from 74 +/- 24 mm Hg before balloon valvuloplasty to 23 +/- 12 mm Hg
  at 5 years. In addition, two patients with isolated pulmonary valve stenosis had
  pulmonary valve dysplasia by angiographic criteria: transpulmonary gradients of
  85 and 56 mm Hg were reduced to 20 and 11 mm Hg, respectively, at 5 years. CONCLUSIONS:
  Relief of obstruction persists at 5 years especially if oversized balloons are used.
  Acceptable results can be obtained in patients with a dysplastic valve. More complete
  relief of right ventricular outflow gradient is associated with increased right
  ventricular dimension, probably because more pulmonary incompetence is induced.
  This is well tolerated at 5 years but may be important in the longer term.'
raw_completion_output: |-
  primary_disease: Pulmonary valve stenosis
  medical_actions: Balloon pulmonary valvuloplasty;Cardiac catheterization;Doppler study
  symptoms: High transpulmonary gradient;Pulmonary incompetence
  chemicals: 
  action_annotation_relationships: Balloon pulmonary valvuloplasty TREATS high transpulmonary gradient IN Pulmonary valve stenosis;Cardiac catheterization TREATS high transpulmonary gradient IN Pulmonary valve stenosis;Doppler study TREATS pulmonary incompetence IN Pulmonary valve stenosis
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Doppler study TREATS pulmonary incompetence IN Pulmonary valve stenosis

  ===

extracted_object:
  primary_disease: MONDO:0006936
  medical_actions:
    - Balloon pulmonary valvuloplasty
    - MAXO:0035118
    - Doppler study
  symptoms:
    - High transpulmonary gradient
    - HP:0010444
  action_annotation_relationships:
    - subject: <Balloon pulmonary valvuloplasty>
      predicate: <TREATS>
      object: <high transpulmonary gradient>
      qualifier: <Pulmonary valve stenosis>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: MAXO:0035118
      predicate: TREATS
      object: high transpulmonary gradient
      qualifier: MONDO:0006936
    - subject: Doppler study
      predicate: TREATS
      object: HP:0010444
      qualifier: MONDO:0006936
named_entities:
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0006936
    label: pulmonary valve stenosis
  - id: MAXO:0009072
    label: surgical repair
  - id: HP:0001642
    label: pulmonary valve stenosis
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: CHEBI:37845
    label: GH
  - id: MONDO:0011908
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: HP:0012209
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0001663
    label: ventricular fibrillation
  - id: HP:0001639
    label: hypertrophic cardiomyopathy
  - id: HP:0032092
    label: left ventricular outflow tract obstruction
  - id: HP:0030828
    label: Wheezing
  - id: CHEBI:90960
    label: Tiotropium
  - id: HP:0002099
    label: bronchial asthma
  - id: MONDO:0007037
    label: Achondroplasia
  - id: MAXO:0000014
    label: radiotherapy
  - id: MAXO:0035118
    label: Cardiac catheterization
  - id: HP:0001659
    label: Aortic regurgitation
  - id: HP:0001004
    label: Lymphedema
  - id: CHEBI:17347
    label: Testosterone
  - id: MONDO:0005516
    label: osteochondrodysplasias
  - id: MONDO:0008300
    label: Prader-Willi syndrome
  - id: MONDO:0000050
    label: Growth Hormone Deficiency (GHD)
  - id: HP:0001510
    label: Poor growth
  - id: MONDO:0007414
    label: Gorham disease
  - id: HP:0012531
    label: Pain
  - id: HP:0010310
    label: Chylothorax
  - id: MONDO:0007893
    label: Noonan syndrome with multiple lentigines
  - id: HP:0001670
    label: asymmetric septal hypertrophy
  - id: MONDO:0011035
    label: Neurofibromatosis-Noonan syndrome
  - id: HP:0000001
    label: acute lymphoblastic leukemia (ALL)
  - id: HP:0000818
    label: endocrinopathies
  - id: HP:0000789
    label: infertility
  - id: MONDO:0019499
    label: Turner syndrome
  - id: MONDO:0006769
    label: Gastroparesis
  - id: MAXO:0000079
    label: Genetic counseling
  - id: HP:0003270
    label: Bloating
  - id: CHEBI:31515
    label: Domperidone
  - id: HP:0002018
    label: nausea
  - id: MAXO:0010032
    label: heart transplantation
  - id: HP:0001635
    label: heart failure
  - id: HP:0031318
    label: myofiber disarray
  - id: CHEBI:68478
    label: everolimus
  - id: MAXO:0001298
    label: therapy
  - id: HP:0003006
    label: neuroblastoma
  - id: MAXO:0025001
    label: cardiac surgery
  - id: HP:0001627
    label: congenital heart disease
  - id: HP:0011675
    label: Arrhythmias
  - id: HP:0002093
    label: Respiratory insufficiency
  - id: HP:0002090
    label: Pneumonia
  - id: HP:0001631
    label: atrial septal defect
  - id: HP:0001999
    label: Dysmorphic facial features
  - id: HP:0000729
    label: Secundum atrial septal defect (ASD)
  - id: HP:0030957
    label: Ventricular septal aneurysm
  - id: HP:0002875
    label: Exertional dyspnea
  - id: HP:0000316
    label: Hypertelorism
  - id: HP:0000914
    label: Shield chest
  - id: HP:0002943
    label: Thoracic scoliosis
  - id: MONDO:0005212
    label: Rhabdomyosarcoma
  - id: HP:0001263
    label: developmental delay
  - id: HP:0005152
    label: congenital cardiomyopathy
  - id: HP:0002027
    label: abdominal pain
  - id: HP:0002019
    label: constipation
  - id: HP:0031500
    label: abdominal mass
  - id: MONDO:0054588
    label: Noonan syndrome-like disorder with loose anagen hair-2 (NSLH2)
  - id: HP:0001252
    label: Hypotonia
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0011097
    label: epileptic spasms
  - id: MONDO:0021060
    label: RASopathies
  - id: HP:0010816
    label: epidermal nevi
  - id: HP:0010815
    label: nevus sebaceous
  - id: MONDO:0007783
    label: King syndrome
  - id: HP:0002047
    label: malignant hyperthermia
  - id: MONDO:0006664
    label: Atrial Septal Defect
  - id: HP:0003010
    label: prolonged bleeding time
  - id: CHEBI:4450
    label: Desmopressin
  - id: CHEBI:15365
    label: aspirin
  - id: MONDO:0007950
    label: mastocytosis
  - id: MONDO:0019565
    label: von Willebrand disease
  - id: HP:6000310
    label: Preterm premature rupture of membranes
  - id: HP:0002089
    label: Pulmonary hypoplasia
  - id: HP:0001256
    label: Mild mental retardation
  - id: HP:0025676
    label: fetal pleural effusions
  - id: MONDO:0006497
    label: Cerebral Palsy
  - id: MONDO:0002192
    label: Vulvar angiokeratoma
  - id: HP:0030692
    label: brain tumors
  - id: CHEBI:119915
    label: Fentanyl
  - id: CHEBI:6931
    label: Midazolam
  - id: CHEBI:44915
    label: Propofol
  - id: CHEBI:6121
    label: Ketamine
  - id: CHEBI:9130
    label: Sevoflurane
  - id: HP:0002593
    label: intestinal lymphangiectasia
  - id: MAXO:0035035
    label: lymphography
  - id: HP:0002243
    label: protein-losing enteropathy
  - id: HP:0001508
    label: failure to thrive
  - id: CHEBI:8499
    label: propranolol
  - id: CHEBI:135083
    label: cibenzoline
  - id: MONDO:0015280
    label: cardiofaciocutaneous syndrome
  - id: HP:0032152
    label: keratosis pilaris (KP)
  - id: HP:0100837
    label: ulerythema ophryogenes (UO)
  - id: HP:0000972
    label: palmoplantar hyperkeratosis (PPHK)
  - id: CHEBI:50172
    label: acitretin
  - id: CHEBI:9168
    label: sirolimus
  - id: CHEBI:31696
    label: Indocyanine green (ICG)
  - id: MAXO:0000127
    label: Genetic testing
  - id: HP:0001680
    label: aortic coarctation
  - id: MONDO:0019383
    label: Acute Disseminated Encephalomyelitis
  - id: HP:0001945
    label: Fever
  - id: HP:0002329
    label: Drowsiness
  - id: CHEBI:6888
    label: Methylprednisolone
  - id: CHEBI:8382
    label: Prednisone
  - id: CHEBI:27902
    label: Tetracycline
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0001610
    label: transcranial magnetic stimulation
  - id: HP:0004415
    label: pulmonary artery stenosis
  - id: MONDO:0009369
    label: Nonimmune hydrops fetalis (NIHF)
  - id: HP:0001790
    label: Nonimmune hydrops fetalis (NIHF)
  - id: CHEBI:40303
    label: Lovastatin
  - id: CHEBI:19226
    label: TMS
  - id: CHEBI:38637
    label: Tyrosine kinase inhibitors
  - id: CHEBI:79091
    label: MEK inhibitors
  - id: HP:0001649
    label: Tachycardia
  - id: HP:0002615
    label: Hypotension
  - id: HP:0032555
    label: Bounding pulses
  - id: HP:0001942
    label: Metabolic acidosis
  - id: CHEBI:6872
    label: Methylene Blue
  - id: CHEBI:18357
    label: Norepinephrine
  - id: CHEBI:18243
    label: Dopamine
  - id: CHEBI:9937
    label: Vasopressin
  - id: MAXO:0000780
    label: Growth hormone (GH) therapy
  - id: MONDO:0005045
    label: Hypertrophic obstructive cardiomyopathy
  - id: HP:0005164
    label: Dysplastic pulmonary valve
  - id: MAXO:0001490
    label: Platelet transfusions
  - id: MONDO:0011331
    label: Congenital chylothorax
  - id: HP:0002202
    label: Pleural effusion
  - id: CHEBI:15904
    label: Long-chain fatty acids (LCFA)
  - id: HP:0000028
    label: cryptorchidism
  - id: HP:0004349
    label: Decreased bone mineral density
  - id: CHEBI:10033
    label: Warfarin
  - id: CHEBI:8093
    label: Phenylephrine
  - id: HP:0002650
    label: scoliosis
  - id: HP:0001655
    label: patent foramen ovale
  - id: HP:0012905
    label: euryblepharon
  - id: HP:0030001
    label: lagophthalmos
  - id: HP:0000271
    label: Facial anomalies
  - id: HP:0001903
    label: anemia
  - id: HP:0010444
    label: Pulmonary incompetence
